Difference between revisions of "Li-Fraumeni syndrome"

Jump to navigation Jump to search
631 bytes added ,  17:41, 24 September 2011
+Li-Fraumeni variant
m (w)
(+Li-Fraumeni variant)
Line 1: Line 1:
'''Li-Fraumeni syndrome''' is due to germline mutations in the gene TP53 (p53),<ref>{{OMIM|191170}}</ref> an important regulator of [[apoptosis]] and the cell cycle, i.e. cell division.  It is implicated in a very large number of sporadic cancer.
'''Li-Fraumeni syndrome''' is due to germline mutations in the gene TP53 (p53),<ref name=omim191170>{{OMIM|191170}}</ref> an important regulator of [[apoptosis]] and the cell cycle, i.e. cell division.  It is implicated in a very large number of sporadic cancer.


Individuals with Li-Fraumeni syndrome are predisposed to cancer.  TP53 is considered to be a tumour suppressor and like most tumour suppressors, inheritance is autosomal dominant.
Individuals with Li-Fraumeni syndrome are predisposed to cancer.  TP53 is considered to be a tumour suppressor and like most tumour suppressors, inheritance is autosomal dominant.
Line 12: Line 12:
*Acute [[leukemia]].<ref name=emed987356ov/>
*Acute [[leukemia]].<ref name=emed987356ov/>
*[[Soft tissue lesions|Soft tissue sarcomas]].<ref name=emed987356ov/>  
*[[Soft tissue lesions|Soft tissue sarcomas]].<ref name=emed987356ov/>  
==Li-Fraumeni variant==
A germline mutation in CHEK2<ref name=omim604373>{{OMIM|604373}}</ref> is considered to a '''Li-Fraumeni variant''', as it interacts with TP53 and BRCA1.
CHEK2 mutation are most strongly associated with [[breast cancer]] and [[colon cancer]]; thus, it is also known as
hereditary breast & colorectal cancer (HBCC).<ref name=omim604373/>  In addition to breast and colon cancers, it has also been associated with prostate and thyroid cancer.<ref>{{Ref PCPBoD8|545}}</ref>
Memory device for ''CHEK2'' - two common cancers above and below the diaphragm:
*Breast.
*Thyroid.
*Colon.
*Kidney.


==See also==
==See also==
48,466

edits

Navigation menu